The China National Medical Products Administration (NMPA) has approved GSK’s Nucala (mepolizumab) as an add-on treatment with ...

Around 50% of asthma attacks and 30% of COPD attacks are "eosinophilic exacerbations ... SHAMAL that showed benralizumab could allow people with asthma to reduce or even stop their use ...

BD (Becton, Dickinson and Company) , a leading global medical technology company, today announced the results of a new survey, revealing that 72% of women in the United States have delayed having a ...

I suppose you might say is when my journey began. I started following Slimming World at home the best I could without actually going, because my self confidence was low and my crippling social anxiety ...

Benralizumab is more effective than prednisolone in treating eosinophilic exacerbations in patients with asthma and COPD.

The association between early childhood serum 25-hydroxyvitamin D (25(OH)D) and eosinophilic asthma remains unclear. We ...

Current treatments focus on eosinophilic asthma, neglecting non-eosinophilic types. Developments in biologic therapies for ...

While the exact cause of asthma is unknown, certain genetic factors can increase the risk of developing the disease.

This is especially true for people with exercise-induced asthma or EIB. For these people, their asthma symptoms are triggered ...

If you don’t have asthma, then you might take for granted your ability to take a deep breath. People who suffer from asthma do not always have that luxury – and sometimes they will need to use ...